MARCHIGNOLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 329
EU - Europa 249
AS - Asia 167
AF - Africa 12
SA - Sud America 3
Totale 760
Nazione #
US - Stati Uniti d'America 328
IT - Italia 101
SG - Singapore 72
CN - Cina 63
GB - Regno Unito 42
DE - Germania 28
SE - Svezia 21
IN - India 15
IE - Irlanda 12
FI - Finlandia 10
BG - Bulgaria 8
RU - Federazione Russa 8
CI - Costa d'Avorio 6
FR - Francia 5
ID - Indonesia 5
TR - Turchia 5
EE - Estonia 3
JO - Giordania 3
ZA - Sudafrica 3
BR - Brasile 2
ES - Italia 2
LB - Libano 2
RS - Serbia 2
TG - Togo 2
AT - Austria 1
BD - Bangladesh 1
BE - Belgio 1
CA - Canada 1
CH - Svizzera 1
EC - Ecuador 1
LT - Lituania 1
NG - Nigeria 1
NL - Olanda 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
Totale 760
Città #
Singapore 65
Santa Clara 42
Southend 37
Bologna 32
Boardman 28
Fairfield 28
Ashburn 27
Chandler 22
Seattle 16
Princeton 14
Dublin 12
Houston 11
Cambridge 9
Sofia 8
Wilmington 8
Woodbridge 8
Helsinki 7
Milan 7
Turin 7
Abidjan 6
Naples 6
Ankara 5
Beijing 4
Berlin 4
Guangzhou 4
Jakarta 4
Trento 4
Amman 3
Ann Arbor 3
Boydton 3
Cesena 3
Chengdu 3
Lappeenranta 3
Leuna 3
Olalla 3
Padova 3
Parma 3
Rimini 3
Riva del Garda 3
Westminster 3
Aracati 2
Barcelona 2
Basiano 2
Frankfurt am Main 2
Genoa 2
Hebei 2
Livorno 2
Lomé 2
London 2
Lucknow 2
Medford 2
Munich 2
Nanchang 2
New York 2
Phoenix 2
Pisa 2
Qingdao 2
Rome 2
San Diego 2
San Francisco 2
Shanghai 2
Shenyang 2
Tianjin 2
Zrenjanin 2
Abeokuta 1
Bhubaneswar 1
Brussels 1
Buffalo 1
Changsha 1
Chicago 1
Chongqing 1
Chuzhou 1
Clearwater 1
Cuenca 1
Dearborn 1
Den Haag 1
Des Moines 1
Dhaka 1
Falkenstein 1
Foshan 1
Gloucester 1
Haikou 1
Harbin 1
Hendon 1
Hyderabad 1
Islamabad 1
Jinan 1
Lapio 1
Linyi 1
Malang 1
Moscow 1
Nantong 1
Norwalk 1
Omsk 1
Paris 1
Pitesti 1
Pune 1
Putian 1
Qiqihar 1
Redmond 1
Totale 548
Nome #
Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? 124
Evidence-based medicine and the problem of healthy volunteers 94
Obesity and NAFLD: Same problem? 66
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 66
NASH: A glance at the landscape of pharmacological treatment 61
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 59
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 56
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 52
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease 44
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs 40
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 35
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 26
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study 23
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey 18
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 15
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 10
Totale 789
Categoria #
all - tutte 3.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 0 0 7 11 9 14 2 2 5
2020/202127 8 3 2 0 0 0 5 0 4 2 0 3
2021/2022119 3 12 6 0 8 6 3 8 12 6 35 20
2022/2023156 9 13 6 12 16 8 11 7 39 7 12 16
2023/2024138 16 14 6 4 10 19 2 10 6 27 11 13
2024/2025240 17 36 62 44 63 18 0 0 0 0 0 0
Totale 789